Withdrawal of Registration Statement (rw)
November 22 2017 - 5:01PM
Edgar (US Regulatory)
MARINA
BIOTECH, INC.
17870
Castleton Street, Suite 250
City
of Industry, CA 91748
VIA
EDGAR
Securities
and Exchange Commission
100
F Street, N.E.
Washington,
D.C. 20549
|
RE:
|
Marina
Biotech, Inc.
|
|
|
Registration
Statement on Form S-1
|
|
|
File
No. 333-218982
|
Ladies
and Gentlemen:
In
accordance with Rule 477 under the Securities Act of 1933, as amended, Marina Biotech, Inc., a Delaware corporation (the “Company”),
hereby requests the withdrawal of the above-referenced Registration Statement on Form S-1 (Reg. No. 333-218982), together with
all exhibits and amendments thereto (the “Registration Statement”), which originally was filed with the Securities
and Exchange Commission (the “Commission”) on June 26, 2017. The Registration Statement, which has not been declared
effective by the Commission, is being withdrawn due to recent changes in the Company’s financing plans. No securities were
sold in connection with the offering to which the Registration Statement related.
The
Company also requests that, in accordance with Rule 457(p) of the Securities Act, all fees paid to the Commission in connection
with the filing of the Registration Statement be credited to the Company’s account for future use.
If
you have any questions regarding the foregoing request for withdrawal, please call Michael T. Campoli at Pryor Cashman LLP, outside
counsel to the Company, at (212) 326-0468.
|
Very
truly yours,
|
|
|
|
/s/
Vuong Trieu
|
|
|
|
Vuong
Trieu, Ph.D.
|
|
Executive
Chairman
|